Starbucks Discontinues Impossible Plant-Based Sandwiches in the U.S. Amid Trend of Reducing Meat Alternative Menus in Food Service

Starbucks will remove the Impossible Breakfast Sandwich from U.S. stores this month, citing menu simplification and reduced demand for plant-based meat. The sandwich, featuring Impossible Foods' patty, will be replaced with other options. Impossible Foods is expanding retail distribution, including in UK supermarkets, amid declining foodservice demand for meat alternatives.

Original reporting
Published Nov 6, 2026, 4:20 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 6, 2026, 5:14 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Starbucks Discontinues Impossible Plant-Based Sandwiches in the U.S. Amid Trend of Reducing Meat Alternative Menus in Food Service — source image
Decision brief

The 30-second read

$SBUXNeutralLow
01

Why it matters

The change is a modest operational adjustment with limited financial impact, but it highlights waning consumer interest in meat alternatives within foodservice.

02

Market read

A niche menu update with minor short‑term price relevance for Starbucks; broader sector signal of reduced plant‑based demand.

03

What to watch

Impossible Foods may increase retail presence, mitigating the impact on Starbucks; the move reflects broader menu simplification, not a failure of the product.

Relevance 4/10Novelty 4/10Timing: today

Background

Starbucks is executing a 2025 menu simplification plan, removing low‑frequency and complex items. The Impossible Breakfast Sandwich has been on the menu since 2020.

Company-level read

Ticker impact

$SBUXNeutralMedium confidence
Context

Starbucks announced it will discontinue the Impossible Breakfast Sandwich in U.S. stores this month, a menu change affecting its plant‑based offering.

Expected impact

likely slight pressure as investors price in reduced plant‑based sales

Evidence & confidence

Menu simplification is a modest operational change; no revenue numbers or guidance were altered, so impact is limited.

Market effects

Signals a slowdown in food‑service demand for plant‑based meat, which could affect other chains with similar offerings.

U.S. coffee/quick‑serve segment may see a minor shift in consumer perception of plant‑based options.

Limited; the story is U.S.-focused and does not alter broader market dynamics.

Counterpoint

The discontinuation could free up shelf space for higher‑margin items, potentially offsetting any loss from the plant‑based line.

Key entities

  • Starbucks

    U.S.-listed coffee chain (ticker SBUX) implementing menu changes.

  • Impossible Foods

    Private plant‑based protein producer supplying the discontinued sandwich.

Related articles

$SBUXHighAI 8/10

Starbucks Sees Annual Profit Above Estimates

Starbucks forecast annual profit above estimates at $3.15-$3.25 EPS, announced a $1B share buyback, and reported Q4 same-store sales growth of 7.2%. However, shares fell 2% after forecasting a 1% revenue decline due to its Chinese business divestiture. CEO Brian Niccol emphasized growth plans and tech investments, including AI for drive-through orders and supply chain improvements.

$SBUXMedAI 8/10

Starbucks Q4 Earnings Call Highlights Turnaround and 2027 Growth Plans

Starbucks (SBUX) reported Q4 adjusted EPS of $0.80, beating estimates, but revenue of $9.14B missed. For 2027, it projects 4% NA comparable sales growth, 13.5-14% operating margin, and EPS of $3.15-$3.25. The company plans digital expansion, menu innovation, and disciplined global growth, with 1,200 new coffeehouses expected.

$SBUXMed

Why Morgan Stanley sees customers spending more at Starbucks

Morgan Stanley raised its 12-18 month price target for Starbucks (SBUX) to $116 from $115 after Q4 results showed a 5.2% increase in U.S. average spend per visit and 2.4% customer growth. Adjusted operating margin expanded 450 basis points year over year to 14.0%, beating expectations. SBUX shares closed at $103.67 on Oct. 30, up 23% year to date. The company's adjusted earnings per share hit $0.80, surpassing Wall Street's $0.72 estimate.